gemfibrozil has been researched along with Airflow Obstruction, Chronic in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Risks of COPD exacerbation events (COPD-related ED visit and COPD-related hospitalization) were estimated by using the cumulative incidence curve and Cox proportional hazards models." | 1.91 | The impact of the duration of the integrated disease management program on COPD-related outcomes. ( Chen, CH; Huang, KY; Kor, CT; Li, YR; Lin, CH; Lin, SH; Wang, BY, 2023) |
| "We found that lungs of smokers and COPD-subjects with increasing emphysema severity demonstrate sphingolipid-imbalance, resulting in significant ceramide-accumulation and increased ceramide/sphingosine ratio, as compared to non-emphysema/non-smoker controls." | 1.51 | Autophagy augmentation alleviates cigarette smoke-induced CFTR-dysfunction, ceramide-accumulation and COPD-emphysema pathogenesis. ( Bodas, M; Gulbins, E; Pehote, G; Silverberg, D; Vij, N, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, CH | 1 |
| Li, YR | 1 |
| Wang, BY | 1 |
| Lin, SH | 1 |
| Huang, KY | 1 |
| Chen, CH | 1 |
| Kor, CT | 1 |
| Bodas, M | 1 |
| Pehote, G | 1 |
| Silverberg, D | 1 |
| Gulbins, E | 1 |
| Vij, N | 1 |
2 other studies available for gemfibrozil and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
The impact of the duration of the integrated disease management program on COPD-related outcomes.
Topics: Disease Management; Female; Gemfibrozil; Humans; Male; Pulmonary Disease, Chronic Obstructive; Retro | 2023 |
Autophagy augmentation alleviates cigarette smoke-induced CFTR-dysfunction, ceramide-accumulation and COPD-emphysema pathogenesis.
Topics: Acid Ceramidase; Animals; Antioxidants; Autophagy; Bronchi; Case-Control Studies; Cell Line; Ceramid | 2019 |